Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Michael L Nieder
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- Children'S Hospital New Orleans
New Orleans, Louisiana, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Corewell Health Grand Rapids Hospitals - Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Children'S Mercy Hospitals and Clinics
Kansas City, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- New York Medical College
Valhalla, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- the Children'S Hospital at Tristar Centennial
Nashville, Tennessee, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- Medical City Dallas Hospital
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2018
- Primary completion
- 30 Jun 2022
- Completion
- 30 Jun 2026
- Last update posted
- 6 Oct 2025
- Registered enrollment
- 173
- Registry id
- NCT03057054
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.